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Overview: 
 Delayed Onset Muscle Soreness (DOMS) is a phenomenon that is experienced 
frequently in the active population.  As the name implies, the onset of muscle soreness 
occurs at a point in time long after the bout of exercise was performed.  DOMS may 
hinder athletic performance through decreases in strength and range of motion (ROM) 
and may cause considerable pain upon movement.  The goal of this paper is to investigate 
different therapeutic modalities as treatment for DOMS and determine which intervention 
produces the most desirable results by way of treating the signs and symptoms associated 
with delayed onset muscle soreness.   
Introduction: 
Delayed onset muscle soreness (DOMS) is a sensation that is experienced among 
the active population following performance of physical activity of a greater than usual 
intensity and/or duration or unaccustomed physical activity.1,2  Of these unfamiliar types 
of exercise, eccentric muscle contractions  (the lengthening phase of muscle contraction) 
have been found to be the leading culprit in the induction of DOMS.1,3  Fewer muscle 
fibers are recruited during eccentric muscle contractions; therefore, there is a higher 
potential for muscle fiber damage to occur during eccentric movements.1  Although bouts 
of eccentric exercises have been found to create the highest occurrence of DOMS, other 
theories have been suggested by researchers.  These theories include: mechanical 
disruption of contractile or connective tissue1,2,3, leakage of muscle protein into 
circulation2, build up of lactic acid2, and muscle spasm.2,3   
Patients experiencing delayed onset muscle soreness have reported a variety of 
signs and symptoms.  DOMS is typically characterized by feelings of muscle soreness 
upon movement or palpation1,3, decreased range of motion1, decreased muscle strength1,3, 
pain1,4, stiffness1,4, swelling1, and loss of muscle function.1  DOMS typically begins to 
become apparent in the overworked muscle tissue 24 hours post exercise and peaks in 
intensity between 24 and 72 hours post exercise.1,2,3,4  After DOMS peaks in intensity it 
generally takes another five to seven days for the signs and symptoms to dissipate.1    
Although the active population commonly experiences delayed onset muscle 
soreness there is not a clearly established therapeutic intervention to treat the signs and 
symptoms accompanying DOMS.  Numerous treatments have been investigated in the 
past and few, if any, were found effective.  The goal of this research paper is to 
investigate the effectiveness of electrical muscle stimulation and low-level laser therapy 
in treating the side effects of DOMS.      
Therapeutic Interventions: 
 Both electrical muscle stimulation and low-level laser therapy have been used in 
some capacity in an attempt to alleviate the signs and symptoms of delayed onset muscle 
soreness in the past.  Weber et al.3 used a microcurrent electrical muscle stimulation 
technique to relieve the soreness accompanying DOMS, but failed to find any significant 
data.  Hashmi et al.4 used a pulsed laser parameter in an effort to eliminate the soreness 
experienced along with DOMS, but also found pulsed laser to be an ineffective treatment 
protocol.  This research paper will explore the effectiveness of other types of muscle 
stimulation and laser therapy techniques to determine their effectiveness in treating 
DOMS.  By exploring these different therapeutic modalities, an answer can be provided 
for the research question: is low-level laser therapy effective for the treatment of delayed 
onset muscle soreness? 
Electrical Muscle Stimulation: 
 Electrical Muscle Stimulation (EMS) produces its primary effects on the body 
through the depolarization of sensory, motor, or nociceptive (pain) nerves.  The electrical 
impulses that are produced by the generator mimic action potentials that arise from the 
central nervous system.  These action potentials will depolarize the nerves in a specific 
order: sensory, motor, then pain depending upon intensity of stimulation.5  In the clinical 
setting EMS can be used for a variety of therapeutic purposes.  The most common 
applications of EMS currents include: controlling acute and chronic pain5,6, reducing 
edema5, reducing muscle spasm5,6, reducing joint contractures5, inhibiting muscle spasm5, 
facilitating tissue healing5,6, and strengthening muscle.5,6        
 For the purpose of this study a premodulated electrical stimulation current was 
used.  Premodulated stimulation currents are created within the electrical generator before 
they are introduced to the tissue.  The integration of the electrical current occurs outside 
of the body, therefore, the amplitude of the current is directly applied to the target tissue 
when it leaves the machine.6  These currents are created by the mixing of alternating 
“carrier” currents of differing frequencies.  When the alternating currents come into 
contact as their phases are in sync, constructive interference is formed which builds a 
larger amplitude wave.  The mixing of currents minimizes skin impedance (skin 
resistance to current flow) and causes a beating effect within the tissue, which causes the 
current amplitude to change constantly.  The two factors mentioned above allow the 
patient to receive the highest amount of stimulation while experiencing the least 
discomfort during treatment.  Premodulated currents are delivered via two electrodes 
placed on the patient’s skin by way of a single electrical channel.  This set up is indicated 
as the use of four electrodes is impractical for the size of the body area being treated.5,6   
Low-Level Laser Therapy: 
 Low-Level Laser Therapy (LLLT) creates its effect on the body by producing 
highly organized beams of light (photons) which stimulate changes at the molecular, 
cellular, and tissue levels.  The two most commonly observed effects of the laser are its 
ability to act on the mitochondria of cells and its specific action on immune cells.  The 
photons produced by the laser enhance the mitochondrion’s ability to produce adenosine 
triphosphate (ATP); which in turn creates changes at the molecular level.5,7  These 
changes include: “stimulation of the electron transport chain, stimulation of the 
mitochondrial respiratory chain…and a reduction in intracellular pH.”5  Lasers affect 
immune cells specifically by influencing lymphocytes.  This allows the lymphocyte to 
activate and divide more rapidly and move more efficiently throughout the body, in turn 
causing an increased rate of healing.7  Other less documented effects include: altered 
nerve conduction velocity, vessel vasodilation and increased circulation, increased 
collagen production, and decreased muscle spasm.5    
 Clinically the laser can be used for a wide array of therapeutic purposes.  These 
reasons include: would healing4,5,7, tissue regeneration4,5,7, relief of acute and chronic 
pain4,5,7, relief of inflammation4,5,7, prevention of tissue death4,7, possible inhibition of 
neurological degeneration4, fracture healing5, treatment of multiple forms of arthritis5, 
and edema reduction.7  As more research is being conducted on the use of laser therapy in 
the clinical setting a variety of other indications for LLLT are certain to be discovered.   
 Exposing body tissue to electromagnetic energy generates the photochemical 
events associated with low-level laser therapy.  These light forms are referred to as low-
level because it uses “light at energy densities that are low compared to other forms of 
laser therapy,”7 and for this reason LLLT is also considered a “cold laser.”5,7  In this 
study a continuous waveform laser was used to treat the signs and symptoms of DOMS.  
In a continuous waveform application the light will constantly be emitted from the laser 
apparatus.  This light wave will be released from the applicator with a relatively stable 
intensity and a coherent, collimated light beam.4,5  A continuous waveform is the gold 
standard for LLLT application4, hence it was chosen for the output parameter in this 
study.  
Research Objectives: 
 The research for this paper was conducted in an effort to meet three objectives: 
1. To determine the effectiveness of low-level laser therapy in the treatment of 
Delayed Onset Muscle Soreness  
2. To compare low-level laser therapy to other traditional treatment methods for 
DOMS 
3. To add to the body of research investigating the uses for low-level laser therapy 
 
Research Methods: 
 The purpose of this research was to measure the effects of premodulated electrical 
stimulation currents and continuous low-level laser therapy on the elbow flexors of a 
group of patients after inducing delayed onset muscle soreness.  The dependent variables 
assessed following each treatment included: elbow flexion, elbow extension, and 
perceived pain.  The independent variable was the therapeutic intervention that each 
participant received in an attempt to treat the signs and symptoms of delayed onset 
muscle soreness. 
Subjects: 
 Ten male and 20 female college aged students (ages 18-30) from The College at 
Brockport were recruited for participation in this research project.  Those considered for 
participation in the project were deemed healthy and free of any upper extremity 
pathology or contraindications to electrical muscle stimulation or laser therapy 
techniques.  Subjects were also required to refrain from any upper extremity resistance 
training exercises or strenuous upper body dominant physical activity for three days prior 
to the start of the investigation and for five days following the initial induction of DOMS.  
The subjects were made aware of the possible side effects associated with each 
therapeutic modality as well as the risks and benefits associated with their voluntary 
participation at an informed consent meeting.  The meeting was followed by a question 
and answer session where subjects could express any concerns they had in regards to 
their participation before signing the official informed consent documents.  The informed 
consent paperwork was screened and approved by the Institutional Review Board at The 
College at Brockport.    
 As the 30 subjects were being selected for participation they were given a patient 
number that was attached to their data to maintain confidentiality.  Each number was then 
input into a computer system that randomly determined which treatment group the 
participant would be a part of for the duration of the study.  The computer generated three 
groups of ten.  The three treatment groups included: premodulated electrical stimulation, 
continuous low-level laser therapy, and a placebo laser treatment. 
  
Outcome Measures: 
 Measurements of patient outcomes (elbow flexion and extension and pain) were 
recorded on six different occasions throughout the duration of the study.  Baseline 
measurements were recorded before the patient underwent the DOMS induction protocol.  
The five other outcome measurements took place after each treatment session was 
completed. 
 The first outcome measure was elbow range of motion (ROM).  These 
measurements were taken with a standard, plastic, universal goniometer8, and recorded in 
degrees of movement at each collection period throughout the study.  Research conducted 
by Gajdosik and Bohannon8 demonstrated that the universal goniometer is a valid and 
reliable instrument for assessing ROM.  Goniometry is a valid assessment of ROM 
because the only outcome that a goniometer will measure is ROM.8  Goniometry is 
deemed most reliable when the same practitioner takes the measurements.8  In an effort to 
produce the most reliable ROM results, the same practitioner took elbow flexion and 
extension measurements at each successive treatment time.  The measurements were 
taken with the patient standing in anatomical position with the center of the goniometer 
aligned with the lateral epicondyle of the humerus.  The stationary arm was in line with 
the length of the humerus pointing to the acromion process, while the moving arm was 
aligned with the radius pointing to the styloid process.  Standardizing the ROM testing 
procedures used, “improve[d] reliability, and goniometric measurements must be reliable 
to be valid.8”   
 Patient pain outcomes were recorded on the Numeric Rating Scale for Pain 
(NRS), which determines the average intensity of pain that the patient has been 
experiencing.  Researchers have shown the NRS to be both a valid and reliable 
assessment of pain.  The NRS is an easy to use, eleven-point scale where pain is rated in 
intensity from zero to ten.  Zero represents “no pain” whereas ten represents the “worst 
possible pain.”9  Pain intensity measurements were recorded following ROM 
measurements after each treatment session was completed.      
DOMS Induction Procedure: 
 To induce delayed onset muscle soreness in the musculature responsible for 
elbow flexion, a modified protocol adopted from Kuligowski et al.1 was used.  Patients 
were first instructed to determine their one repetition maximum (1-RM) for a bicep curl.  
Starting with a five-pound weight the participant was instructed to lift the weight twice.  
If the participant successfully completed the lift twice he/she was instructed to increase 
the weight of the dumbbell by five pounds.  Patients continued to lift the dumbbells in 
five-pound increments until they could only complete one repetition with the selected 
weight.1  The 1-RM for each patient was recorded and the patient then performed the 
DOMS induction protocol with that weight.   
 The patients assumed the starting position with their arm in full elbow flexion and 
complete supination of the forearm.  The exercise was performed on an incline bench to 
Figure	1:	The	Numeric	Rating	Scale	for	Pain 
prevent hyperextension of the elbow during each repetition.  The weight was placed in 
the subject’s hand by the researcher as they held the aforementioned position.  Once the 
weight was placed in the patient’s hand, they were instructed to lower the weight on a 
five-second count.  After each repetition the researcher returned the patient’s arm, with 
the dumbbell in hand, to the starting position.  The patient completed the eccentric 
lowering of the weight until ten repetitions were completed or until the bicep muscle 
fatigued (fatigue was classified as the inability to lower the weight for the full five-
second count).  After the successful completion of ten repetitions, or patient fatigue, a 
one-minute rest period was given to the subjects.  The patient repeated this eccentric 
exercise cycle five times, performing a maximum of 50 total repetitions throughout the 
duration of the protocol.1      
Treatments and Post-treatment Retests: 
 Immediately following the delayed onset muscle soreness induction protocol the 
patients received their first treatment.  As mentioned above, the patients were either 
assigned to a premodulated electrical stimulation group, low-level laser therapy group, or 
a placebo laser treatment group.  Immediately following their treatments, the outcome 
measures of elbow flexion, elbow extension, and perceived pain were recorded.  The 
following sections detail the specific parameters used to treat the signs and symptoms of 
DOMS. 
 Group one received the premodulated electrical stimulation treatment for a 15-
minute period of time.  This treatment was delivered by way of two electrodes placed on 
the biceps brachii muscle.  The pads were placed at the proximal and distal belly of the 
biceps muscle, which allowed the current to spread throughout the length of the muscle.  
The premodulated current was delivered at a strong sensory level, which is reached by 
increasing the current output to a level where a slight muscle contraction is felt and then 
decreasing the intensity by roughly five percent.5  Research has shown that electrical 
stimulation at a sub-motor (sensory) level has, “positive effects on postexercise muscle 
soreness and thus exercise recovery.”10  These findings support the rationale to use a 
premodulated current at a strong sensory level in an attempt to reduce the signs and 
symptoms of DOMS.   
 Group two was administered low-level laser therapy.  This treatment was given at 
four locations along the length of the biceps brachii muscle.  These locations included: 
the origin of the muscle, the insertion of the muscle, and two equidistant points in the 
belly of the biceps muscle.  Each location was treated for a duration of 23 seconds with a 
continuous wave light being applied to the participant’s tissue.  Continuous wave laser is 
the gold standard for laser therapy and has been shown to promote quicker nerve and 
muscle recovery than its pulsed wave counterpart.4  Therefore, a continuous light 
application was selected for the purpose of this research paper to treat delayed onset 
muscle soreness.    
 Group three received a placebo treatment as the control group.  A sham laser 
treatment was given to each participant in this group.  Like the authentic laser treatment, 
the duration of time spent at each location was 23 seconds.  The applicator head was 
placed along the same four locations as that of the true laser group (origin of the muscle, 
insertion of the muscle, and two equidistant sites in the belly of the muscle), but no light 
waves were emitted from the generator.   
 Five total treatments were administered to the patients throughout the length of 
the study.  Directly following the conclusion of each treatment the participants were 
instructed to have their outcomes measures of elbow flexion and extension and pain 
reassessed.  These reassessment periods were conducted at zero (immediately after the 
first treatment), 24, 48, 72, and 96 hours post-exercise.    
Statistical Analysis: 
 The data was statistically analyzed using SPSS version 22.  Before any true 
statistical analysis was performed, the data was tested for normality.  T-tests, with a 
significance level of α = 0.05, were completed for each group (premodulated stimulation, 
LLLT, and placebo LLLT) and each parameter measured (flexion, extension, and pain) as 
well as for the combined data set for all three groups.  The T-tests were designed to 
determine if there was any significance from baseline measures to measurements taken at 
hour 96.  A six-factor repeated measure ANOVA, with a significance level of α = 0.05, 
was performed to analyze the variance among groups.  The assumption of sphericity was 
violated based upon calculations with Mauchly’s test for sphericity; therefore, the degrees 
of freedom were modified based upon the Greenhouse-Geisser epsilon correction factor.    
Results: 
 The normality testing showed that there were no significant outliers or missing 
data points and based upon the Q-Q plots the data sets were normally distributed.  T-
testing for the placebo laser treatment group revealed that there was significance for the 
outcome of pain, a value of (0.045).  The outcome measures of flexion (0.406) and 
extension (0.696) for this group did not produce significant T-test results.  Premodulated 
electrical stimulation produced no significant results in the treatment of the signs and 
symptoms of delayed onset muscle soreness.  The results for each outcome are as 
follows: pain (0.052), flexion (0.096), and extension (0.162).  Low-level laser therapy 
exhibited no significant results through T-testing each variable.  The results showed 
values of (0.143) for pain, (0.624) for flexion, and (0.776) for extension.  The results of 
the combined T-test indicated a significant value for the outcome of pain (0.001), but no 
statistical significance for flexion (0.327) or extension (0.395) range of motion 
measurements.  The repeated measures ANOVA tested the within subjects effects of each 
therapeutic modality on the signs and symptoms of delayed onset muscle soreness.  The 
results revealed that over a 96-hour time period no significance existed between any of 
the three treatment conditions; (0.756) for pain, (0.485) for flexion, and (0.538) on the 
behalf of extension measurements. 
The charts below display the average value for each patient outcome throughout 
the duration of the study.  Each therapeutic modality is shown on its own line in an effort 
to visually compare and contrast the effectiveness of each treatment for the signs and 
symptoms of delayed onset muscle soreness.	
	Figure	2:	Average	flexion	measurements	for	each	group	at	each	treatment	session 
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		Figure	3:	Average	extension	measurements	for	each	group	at	each	treatment	session 
 	
	
	Figure	4:	Average	pain	scores	for	each	group	at	each	treatment	session	
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Discussion: 
 Upon analysis of the data produced by each individual a substantial increase in 
perceived pain near hour 48 was noticeable.  This suggests that the protocol used to 
induce delayed onset muscle soreness was effective.  The patients in the placebo group 
reported an average of 4.7 out of 10 for pain scores at hour 48.  Those in the electric 
stimulation group reported 3.9 out of 10 and the LLLT group described pain as an 
average of 3.7 out of 10 on the numeric rating scale for pain at hour 48.   
Statistical analysis demonstrated that neither premodulated stimulation or low-
level laser therapy were effective treatments for reducing the signs and symptoms related 
to DOMS.  T-tests showed that after a series of treatments, over a duration of 96 hours, 
patients did not return to their baseline measurements for perceived soreness or elbow 
flexion and extension.  The ANOVA’s also displayed no significant results, which means 
that there were not any significant differences among the treatment groups over the given 
time period.  According to the results neither treatment was effective; however, if given a 
choice between premodulated stimulation and LLLT to treat DOMS it would be more 
beneficial to choose a premodulated current.   The electrical current proved to relieve the 
patients’ signs and symptoms more quickly than LLLT.   
Based upon the data produced throughout the course of the study, many 
hypotheses have been formulated as to why particular results were achieved for each 
treatment group and each variable.  In regards to flexion measurements, the muscle 
stimulation group encountered the largest drop in elbow flexion at hour zero.  This is 
most likely attributed to the electrical current continually stressing the muscle fibers 
immediately after the treatment.  This factor increased the initial fatigue of the muscle 
due to the additional stress, and thereby decreased ROM into flexion.  This initial drop in 
flexion meant that the premodulated stimulation group had a larger ROM deficit to 
overcome to achieve baseline levels after 96 hours.  The LLLT group was the closest to 
achieving baseline flexion measurements after 96 hours.  This can be credited to the 
photochemical events responsible for reducing inflammation and muscle spasm, thus 
increasing ROM.   
The outcome measure of extension suffered for each group because the patients 
carried their arms in a slightly flexed position, as if they were in a sling.  By holding the 
arm in that position, the muscle remained in a constantly shortened state.  The 
combination of pain, stiffness, and muscle spasm associated with DOMS prevented the 
subjects from moving their arms into extension comfortably, therefore many patients 
refused to move their arms at all.  The premodulated stimulation group showed slightly 
better measures of extension at hour 96.  The hypothesis for this phenomenon is that the 
subjects who were treated with muscle stimulation were treated in an extended position 
whereas those treated with LLLT were in a flexed position.  By allowing the muscle to 
stretch for the duration of treatment those in the stimulation group recovered their 
baseline ROM more quickly than those who were treated in a flexed position.  
In regards to pain measures, premodulated stimulation and LLLT were 
comparable in reducing the pain and soreness associated with DOMS.  Although neither 
treatment was deemed truly effective, patients in both groups expressed subjective relief 
either during or after the treatment was administered.  Those who received LLLT 
reported a steady decline in pain after the peak of DOMS, but not immediately after the 
treatment was given.  Members of the premodulated stimulation group reported pain 
relief during treatment while the arm was at rest but claimed that pain levels increased 
upon performance of daily activities after the treatment had concluded.   
The placebo laser treatment group had no effects on the healing process and the 
results showed the most unfavorable outcomes for all three dependent variables.  These 
findings can be credited to the circumstance that no therapeutic intervention was 
introduced to the body in an attempt promote an atmosphere for healing or to slow the 
rate of cell death.  When comparing the results of the body’s natural timeframe for 
healing to the use of a treatment such as LLLT or premodulated stimulation, results show 
that it is better to use some form of treatment rather than no treatment at all.  The placebo 
group did present a unique finding though.  T-testing showed that the placebo group was 
significant in controlling pain in the subjects who participated in the experiment.  This 
phenomenon may be directly related to the placebo effect.   
The placebo effect is a description of “pain reduction obtained through 
mechanisms other than those related to the physiological effects of the treatment.”5  In 
other words, the placebo effect is related to the cognitive and psychological aspects of 
pain, rather than the physical healing mechanisms within the body.  If the patient believes 
that the treatment will work, there will be a degree of pain reduction although there are 
no physical changes occurring to the injured tissue.  Although the control group, which 
received placebo laser treatment, did not have any medium introduced to the tissue, they 
experienced the most significant value of pain reduction.  This can be directly related to 
the placebo effect.  Since the patient was told how the modality would work and they 
believed that it would make them feel better, they actually experienced pain relief with 
the use of a sham treatment.5 
The placebo effect has been researched on a wide variety of therapeutic 
modalities and it has been demonstrated that all modalities produce some degree of a 
placebo effect.  This might also explain the fact that although the premodulated 
stimulation and the low-level laser therapy groups did not produce significant data, the 
participants still expressed pain relief upon treatment.  As is the case with many other 
experiments, the patients believed that the treatment was working for them despite hard 
evidence to prove that they were experiencing pain relief.5          
Objective and subjective patient data must be explored to answer the question: Is 
low-level laser therapy effective for the treatment of delayed onset muscle soreness?  
Objectively, the results of the statistical analysis did not display a quantitative 
significance for LLLT as a treatment for the signs and symptoms of DOMS.  However, 
subjectively patients reported decreases in the pain and stiffness associated with DOMS, 
which could be directly related to the placebo effect of the LLLT treatment itself.   
Conclusion: 
  As mentioned previously, DOMS is frequently experienced in the athletic 
population after an unaccustomed bout of strenuous exercise.  The signs and symptoms of 
DOMS generally peak between 24 and 72 hours after the completion of the bout of 
exercise.  Despite the fact that DOMS is commonly experienced in the active population, 
there is no treatment protocol deemed significantly effective at treating the signs and 
symptoms of delayed onset muscle soreness.  The goal of this research was to determine 
if low-level laser therapy was an effective treatment for the signs and symptoms of 
DOMS.  The statistical analysis revealed that LLLT was not effective in restoring range 
of motion or pain scores to baseline levels after the completion of five treatments.  
Physiological healing must not be the only factor taken into consideration though.  
Clinicians must take into effect the presence of the placebo effect and how it influences 
psychological healing.  If the patient believes in the effects of the treatment they will 
experience pain relief to a certain extent.  There is no “gold standard” for the treatment of 
DOMS and therefore additional research should be conducted exploring other therapeutic 
modalities as a treatment for its signs and symptoms. 
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